Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model-Reply

Affiliations

Comment

Pardeep S Jhund et al. JAMA Cardiol. 2022.

. 2022 May 1;7(5):570.

doi: 10.1001/jamacardio.2021.6032.

¹ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.

No abstract available

Comment on

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial.
Docherty KF, Jhund PS, Claggett B, Ferreira JP, Bengtsson O, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD, McMurray JJV; DAPA-HF Investigators and Committees. Docherty KF, et al. JAMA Cardiol. 2021 Nov 1;6(11):1298-1305. doi: 10.1001/jamacardio.2021.2632. JAMA Cardiol. 2021. PMID: 34319398 Free PMC article. Clinical Trial.
Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model.
Messori A, Mengato D, Chiumente M. Messori A, et al. JAMA Cardiol. 2022 May 1;7(5):569-570. doi: 10.1001/jamacardio.2021.6029. JAMA Cardiol. 2022. PMID: 35234811 No abstract available.